Table 1 The characteristics of patients with PAP and control group
From: CYFRA21-1 is a more sensitive biomarker to assess the severity of pulmonary alveolar proteinosis
Group | PAP group | % | Control group | % | P value |
|---|---|---|---|---|---|
Subjects, n | 151 | 57 | |||
Age, years | 47.3 ± 11.6 | 47.9 ± 13.4 | 0.731 | ||
Sex | |||||
Male | 108 | 71.5 | 40 | 70.2 | 0.849 |
Female | 43 | 28.5 | 17 | 29.8 | |
Onset age, years | 45.8 ± 11.5 | ||||
Course of disease, months | 18.2 ± 25.6 | ||||
Smoking status | 64 | 42.4 | |||
Symptoms | |||||
Asymptomatic | 16 | 10.6 | |||
Cough | 109 | 72.2 | |||
Dyspnea | 91 | 60.3 | |||
Chest pain | 9 | 6.0 | |||